These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15742623)

  • 1. Vaccination in the control strategy of bluetongue in Italy.
    Caporale V; Giovannini A; Patta C; Calistri P; Nannini D; Santucci U
    Dev Biol (Basel); 2004; 119():113-27. PubMed ID: 15742623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bluetongue vaccination in Europe: the Italian experience.
    Patta C; Giovannini A; Rolesu S; Nannini D; Savini G; Calistri P; Santucci U; Caporale V
    Vet Ital; 2004; 40(4):601-10. PubMed ID: 20422595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bluetongue in Italy: Part II.
    Giovannini A; Calistri P; Nannini D; Paladini C; Santucci U; Patta C; Caporale V
    Vet Ital; 2004; 40(3):252-9. PubMed ID: 20419673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk analysis on the introduction into free territories of vaccinated animals from restricted zones.
    Giovannini A; Conte A; Calistri P; Di Francesco C; Caporale V
    Vet Ital; 2004; 40(4):697-702. PubMed ID: 20422617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of human interventions on the spread of bluetongue virus serotype 8 during the 2006 epidemic in north-western Europe.
    Mintiens K; Méroc E; Faes C; Abrahantes JC; Hendrickx G; Staubach C; Gerbier G; Elbers AR; Aerts M; De Clercq K
    Prev Vet Med; 2008 Oct; 87(1-2):145-61. PubMed ID: 18649960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bluetongue, current situation].
    van Houten D
    Tijdschr Diergeneeskd; 2009 May; 134(9):409-10. PubMed ID: 19480153
    [No Abstract]   [Full Text] [Related]  

  • 7. Possible routes of introduction of bluetongue virus serotype 8 into the epicentre of the 2006 epidemic in north-western Europe.
    Mintiens K; Méroc E; Mellor PS; Staubach C; Gerbier G; Elbers AR; Hendrickx G; De Clercq K
    Prev Vet Med; 2008 Oct; 87(1-2):131-44. PubMed ID: 18667252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of a web-based interactive geographical information system for the surveillance of bluetongue in Italy.
    Conte A; Colangeli P; Ippoliti C; Paladini C; Ambrosini M; Savini L; Dall'Acqua F; Calistri P
    Rev Sci Tech; 2005 Dec; 24(3):857-68. PubMed ID: 16642756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of the surveillance and intervention programme for bluetongue virus serotype 8 in Switzerland.
    Häsler B; Howe KS; Di Labio E; Schwermer H; Stärk KD
    Prev Vet Med; 2012 Feb; 103(2-3):93-111. PubMed ID: 22018548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bluetongue virus surveillance in a newly infected area.
    Giovannini A; Calistri P; Conte A; Savini L; Nannini D; Patta C; Santucci U; Caporale V
    Vet Ital; 2004; 40(3):188-97. PubMed ID: 20419661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines against bluetongue in Europe.
    Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active circulation of bluetongue vaccine virus serotype-2 among unvaccinated cattle in central Italy.
    Ferrari G; De Liberato C; Scavia G; Lorenzetti R; Zini M; Farina F; Magliano A; Cardeti G; Scholl F; Guidoni M; Scicluna MT; Amaddeo D; Scaramozzino P; Autorino GL
    Prev Vet Med; 2005 May; 68(2-4):103-13. PubMed ID: 15820110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the consequences of an incursion of a vector-borne disease. II. Spread of bluetongue in Scotland and impact of vaccination.
    Szmaragd C; Gunn GJ; Gubbins S
    Epidemics; 2010 Sep; 2(3):139-147. PubMed ID: 21352784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some epidemiological and economic aspects of a bluetongue-like disease in cattle in South Africa--1995/96 and 1997.
    Barnard BJ; Gerdes GH; Meiswinkel R
    Onderstepoort J Vet Res; 1998 Sep; 65(3):145-51. PubMed ID: 9809318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing the spread of bluetongue virus at the end of the 2006 epidemic in Belgium.
    Méroc E; Faes C; Herr C; Staubach C; Verheyden B; Vanbinst T; Vandenbussche F; Hooyberghs J; Aerts M; De Clercq K; Mintiens K
    Vet Microbiol; 2008 Sep; 131(1-2):133-44. PubMed ID: 18479845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation between field and vaccine strain of bluetongue virus serotype 16.
    Monaco F; Cammà C; Serini S; Savini G
    Vet Microbiol; 2006 Aug; 116(1-3):45-52. PubMed ID: 16713688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. France to roll out bluetongue vaccination following outbreak.
    Vet Rec; 2015 Sep; 177(11):271. PubMed ID: 26385136
    [No Abstract]   [Full Text] [Related]  

  • 18. The Culicoides 'snapshot': a novel approach used to assess vector densities widely and rapidly during the 2006 outbreak of bluetongue (BT) in The Netherlands.
    Meiswinkel R; Goffredo M; Leijs P; Conte A
    Prev Vet Med; 2008 Oct; 87(1-2):98-118. PubMed ID: 18657871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bluetongue in the United States.
    Callis J
    Prog Clin Biol Res; 1985; 178():37-42. PubMed ID: 2989874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of bluetongue in an epizootic situation: Australian plans.
    Geering WA
    Aust Vet J; 1975 Apr; 51(4):220-32. PubMed ID: 169798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.